Literature DB >> 2337866

The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging.

H C Fernando1, P Goldstraw.   

Abstract

The records of 103 patients undergoing thoracotomy for carcinoma of the lung between 1985 and 1988 were reviewed. All patients underwent a uniform staging protocol in the construction of a clinical evaluative stage (cTNM). Using information obtained at thoracotomy supplemented by pathological examination a more accurate stage was constructed (pTNM). We have evaluated the accuracy of cTNM staging using the pTNM staging constructed following thoracotomy. In 46.6% patients cTN and pTN concurred. When comparing T subsets alone 81.6% patients remained unchanged. On comparing nodal staging alone 55.3% patients remained unchanged. Pre-operative evaluation underestimated far more commonly than it overestimated. Mediastinal node involvement was not overestimated since any suggestion of such involvement was confirmed by mediastinal exploration. Construction of a cTNM stage remains a crude evaluation, but we remain convinced that the major aspect of pre-operative evaluation is the exclusion of gross mediastinal gland involvement by mediastinal exploration.

Entities:  

Mesh:

Year:  1990        PMID: 2337866     DOI: 10.1002/1097-0142(19900601)65:11<2503::aid-cncr2820651119>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  The impact of surgery on the multidisciplinary treatment of bronchogenic small cell carcinoma (updated review including ongoing studies).

Authors:  W Theuer; O Selawry; K Karrer
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

2.  Endoscopy assisted microthoracotomy.

Authors:  P Goldstraw
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

3.  The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer.

Authors:  P Goldstraw
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

4.  Clinical application of positron emission tomography in designing radiation fields in non-small cell lung cancer patients.

Authors:  Alexander Lin; Charles Wood; Christine Hill-Kayser; Rosemarie Mick; Larry Kaiser; James Metz
Journal:  Exp Ther Med       Date:  2010-09-29       Impact factor: 2.447

5.  Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients.

Authors:  Baykal Tulek; Habibe Koylu; Fikret Kanat; Ugur Arslan; Faruk Ozer
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.